What AI says about X4 Pharmaceuticals

X4 Pharmaceuticals is a biopharmaceutical company focused on developing therapies for rare immune disorders. Their product XOLREMDI (mavorixafor) is the first authorized treatment for patients with WHIM syndrome in the European Union.